Mount Sinai: Mount Sinai Health System Launches Center for Psychedelic Research

Summary: Congratulations to the Icahn School of Medicine at Mount Sinai for their launch of the Center for Psychedelic Psychotherapy and Trauma Research! “The Center will focus on studying MDMA, psilocybin, and other psychedelic compounds,” with an emphasis on training, education, clinical trials, and translational neuroscience research, according to Mount Sinai. “It is important that we listen to people’s subjective experiences with these compounds and then study therapeutic possibilities through rigorous clinical trials,” says Director Rachel Yehuda, Ph.D.

Originally appearing here.